Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.68 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.68 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.66 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8052592 | 0.95 | HDAC6 (0.70) | HDAC6 | |
| SCHEMBL8062177 | 0.94 | — | — | |
| SCHEMBL8064420 | 0.93 | HDAC6 (0.80) | HDAC6MEN1KMT2ACYP1A1CYP1B1 | |
| SCHEMBL8069068 | 0.92 | HDAC6 (0.74) | HDAC6MEN1TP53ABCB1MDM2 | |
| SCHEMBL30375958 | 0.89 | HDAC6 (0.84) | HDAC6MEN1TP53ABCB1MDM2 | |
| SCHEMBL7606758 | 0.89 | HDAC6 (0.84) | HDAC6MEN1TP53ABCB1MDM2 | |
| SCHEMBL8052889 | 0.88 | HDAC6 (0.78) | HDAC6CYP1A1CYP1B1CYP1A2OPRD1 | |
| SCHEMBL8064417 | 0.87 | HDAC6 (0.77) | HDAC6CYP1A1CYP1B1CYP1A2OPRD1 | |
| SCHEMBL8052891 | 0.84 | HDAC6 (0.69) | HDAC6MEN1TP53ABCB1MDM2 | |
| SCHEMBL8064232 | 0.84 | HDAC6 (0.83) | HDAC6MEN1TP53ABCB1MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6025387-A | Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease | DONG A PHARMACEUTICAL CO., LTD. (KR) | 2000-02-15 | — | — | US | disclosed |